Disagreement between industry and consumer groups over the frequency that clinical trial data should form the basis of a 510(k) for a device with different technological characteristics from the predicate was evident in comments submitted on a recent FDA draft guidance.
Device companies say non-clinical data should be given more prominence in the final version of the guidance on benefit-risk factors to consider when determining substantial equivalence of 510(k) devices with different technological characteristics from a predicate
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?